Guido Baselli
Overview
Explore the profile of Guido Baselli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
1867
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Croci G, Vaira V, Trabattoni D, Biasin M, Valenti L, Baselli G, et al.
Cells
. 2021 Apr;
10(3).
PMID: 33801959
We herein characterize the immunopathological features of two Italian COVID-19 patients who underwent bilateral lung transplantation (bLTx). Removed lungs underwent histopathological evaluation. Gene expression profiling (GEP) for immune-related signatures was...
12.
Manunta M, Lamorte G, Ferrari F, Trombetta E, Tirone M, Bianco C, et al.
Sci Rep
. 2021 Mar;
11(1):4904.
PMID: 33649400
SARS-CoV-2 virus infection is responsible for coronavirus disease (COVID-19), which is characterised by a hyperinflammatory response that plays a major role in determining the respiratory and immune-mediated complications of this...
13.
Valenti L, Bergna A, Pelusi S, Facciotti F, Lai A, Tarkowski M, et al.
Blood Transfus
. 2021 Feb;
19(3):181-189.
PMID: 33539289
Background: The Milan metropolitan area in Northern Italy was among the most severely hit by the SARS-CoV-2 outbreak. The aim of this study was to examine the seroprevalence trends of...
14.
Jamialahmadi O, Mancina R, Ciociola E, Tavaglione F, Luukkonen P, Baselli G, et al.
Gastroenterology
. 2020 Dec;
160(5):1634-1646.e7.
PMID: 33347879
Background & Aims: Fatty liver disease (FLD) is a growing epidemic that is expected to be the leading cause of end-stage liver disease within the next decade. Both environmental and...
15.
Bianco C, Jamialahmadi O, Pelusi S, Baselli G, Dongiovanni P, Zanoni I, et al.
J Hepatol
. 2020 Nov;
74(4):775-782.
PMID: 33248170
Background & Aims: Hepatocellular carcinoma (HCC) risk stratification in individuals with dysmetabolism is a major unmet need. Genetic predisposition contributes to non-alcoholic fatty liver disease (NAFLD). We aimed to exploit...
16.
Bianco C, Baselli G, Malvestiti F, Santoro L, Pelusi S, Manunta M, et al.
Liver Int
. 2020 Oct;
41(1):227-229.
PMID: 33098230
No abstract available.
17.
Valenti L, Villa S, Baselli G, Temporiti R, Bandera A, Scudeller L, et al.
Transfusion
. 2020 Oct;
60(12):3067-3070.
PMID: 33009662
No abstract available.
18.
Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, et al.
N Engl J Med
. 2020 Jun;
383(16):1522-1534.
PMID: 32558485
Background: There is considerable variation in disease behavior among patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19). Genomewide association analysis...
19.
Tanaka Y, Shimanaka Y, Caddeo A, Kubo T, Mao Y, Kubota T, et al.
Gut
. 2020 Apr;
70(1):180-193.
PMID: 32253259
Objective: Non-alcoholic fatty liver disease (NAFLD) is a common prelude to cirrhosis and hepatocellular carcinoma. The genetic variant in the lysophosphatidylinositol acyltransferase 1 (, which incorporates arachidonic acid into phosphatidylinositol...
20.
Mantovani A, Taliento A, Zusi C, Baselli G, Prati D, Granata S, et al.
Liver Int
. 2020 Mar;
40(5):1130-1141.
PMID: 32125756
Background And Aims: Emerging evidence suggests an association between patatin-like phospholipase domain-containing protein-3 (PNPLA3) rs738409 (I148M protein variant) and risk of chronic kidney disease (CKD), but the mechanisms underpinning this...